Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 311.06M | $ 304.43M | $ 364.46M | $ 377.87M | $ 417.91M |
Total Assets | $ 1.61B | $ 1.66B | $ 1.55B | $ 1.64B | $ 1.60B |
Total Debt | $ 17.19M | $ 18.84M | $ ― | $ 930.00K | $ 1.14M |
Net Debt | $ -293.87M | $ -285.58M | $ ― | $ -376.94M | $ -416.77M |
Total Liabilities | $ 429.20M | $ 437.59M | $ 322.18M | $ 388.15M | $ 355.25M |
Stockholders Equity | $ 1.17B | $ 1.21B | $ 1.22B | $ 1.24B | $ 1.24B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |